$CVRX
CVRx, Inc.

2023 Q4 Form 10-Q Financial Statement

#000155837023017121 Filed on October 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $11.31M $10.51M
YoY Change 57.54% 69.92%
Cost Of Revenue $1.720M $1.691M
YoY Change 13.98% 26.19%
Gross Profit $9.585M $8.820M
YoY Change 69.14% 82.01%
Gross Profit Margin 84.79% 83.91%
Selling, General & Admin $17.01M $15.65M
YoY Change 20.6% 23.45%
% of Gross Profit 177.41% 177.46%
Research & Development $2.241M $2.696M
YoY Change -26.43% 17.58%
% of Gross Profit 23.38% 30.57%
Depreciation & Amortization $132.0K $137.0K
YoY Change 3.13% 7.87%
% of Gross Profit 1.38% 1.55%
Operating Expenses $19.25M $18.35M
YoY Change 12.25% 22.55%
Operating Profit -$9.661M -$9.528M
YoY Change -15.84% -5.91%
Interest Expense -$579.0K $499.0K
YoY Change 250.91%
% of Operating Profit
Other Income/Expense, Net $1.116M $1.056M
YoY Change -1.76% 221.95%
Pretax Income -$9.124M -$8.971M
YoY Change -13.17% -8.44%
Income Tax $39.00K $40.00K
% Of Pretax Income
Net Earnings -$9.163M -$9.011M
YoY Change -13.03% -8.33%
Net Earnings / Revenue -81.05% -85.73%
Basic Earnings Per Share -$0.43
Diluted Earnings Per Share -$0.44 -$0.43
COMMON SHARES
Basic Shares Outstanding 20.82M 20.76M
Diluted Shares Outstanding 20.80M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.57M $83.00M
YoY Change -14.71% -24.54%
Cash & Equivalents $90.57M $82.99M
Short-Term Investments
Other Short-Term Assets $2.987M $3.300M
YoY Change -29.27% 7.63%
Inventory $10.98M $10.89M
Prepaid Expenses
Receivables $7.551M $6.372M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.1M $103.6M
YoY Change -8.78% -16.73%
LONG-TERM ASSETS
Property, Plant & Equipment $3.112M $1.723M
YoY Change 53.15% -1.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.00K $26.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $3.139M $2.807M
YoY Change 52.45% 29.71%
TOTAL ASSETS
Total Short-Term Assets $112.1M $103.6M
Total Long-Term Assets $3.139M $2.807M
Total Assets $115.2M $106.4M
YoY Change -7.77% -15.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.884M $1.133M
YoY Change 9.6% -11.21%
Accrued Expenses $5.980M $6.274M
YoY Change -6.11% 2.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.864M $7.407M
YoY Change -2.77% 0.15%
LONG-TERM LIABILITIES
Long-Term Debt $29.22M $14.29M
YoY Change 333.11%
Other Long-Term Liabilities $2.196M $960.0K
YoY Change 138.18% 26.15%
Total Long-Term Liabilities $31.42M $15.25M
YoY Change 309.68% 1904.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.864M $7.407M
Total Long-Term Liabilities $31.42M $15.25M
Total Liabilities $39.28M $23.58M
YoY Change 149.3% 182.97%
SHAREHOLDERS EQUITY
Retained Earnings -$477.4M -$468.2M
YoY Change 9.45% 10.0%
Common Stock $553.5M $551.3M
YoY Change 1.46% 1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.95M $82.83M
YoY Change
Total Liabilities & Shareholders Equity $115.2M $106.4M
YoY Change -7.77% -15.94%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.163M -$9.011M
YoY Change -13.03% -8.33%
Depreciation, Depletion And Amortization $132.0K $137.0K
YoY Change 3.13% 7.87%
Cash From Operating Activities -$7.841M -$8.120M
YoY Change -27.67% -26.82%
INVESTING ACTIVITIES
Capital Expenditures $171.0K $40.00K
YoY Change 116.46% -115.15%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$171.0K -$40.00K
YoY Change 116.46% -84.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.58M 360.0K
YoY Change 118.97% 5042.86%
NET CHANGE
Cash From Operating Activities -7.841M -8.120M
Cash From Investing Activities -171.0K -40.00K
Cash From Financing Activities 15.58M 360.0K
Net Change In Cash 7.572M -7.800M
YoY Change -299.11% -31.3%
FREE CASH FLOW
Cash From Operating Activities -$7.841M -$8.120M
Capital Expenditures $171.0K $40.00K
Free Cash Flow -$8.012M -$8.160M
YoY Change -26.63% -24.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20801350
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20576838
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20730024
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20512254
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
dei Entity Central Index Key
EntityCentralIndexKey
0001235912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20813612
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20663736
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40545
dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
dei City Area Code
CityAreaCode
763
dei Local Phone Number
LocalPhoneNumber
416-2840
dei Security12b Title
Security12bTitle
Common stock,
dei Trading Symbol
TradingSymbol
CVRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20815635
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82993000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106194000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
506000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
679000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6372000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5504000
CY2023Q3 us-gaap Inventory Net
InventoryNet
10887000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3345000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4223000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
103597000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
122878000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1723000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1058000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
334000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2023Q3 us-gaap Assets
Assets
106404000
CY2022Q4 us-gaap Assets
Assets
124937000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1133000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1719000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6274000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7407000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8088000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14294000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6747000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
916000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
960000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
805000
CY2023Q3 us-gaap Liabilities
Liabilities
23577000
CY2022Q4 us-gaap Liabilities
Liabilities
15757000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20813612
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20663736
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
208000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
207000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
551045000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
545362000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-468218000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-436182000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-208000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
82827000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106404000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124937000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10511000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6186000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27990000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15293000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1691000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1340000
us-gaap Cost Of Revenue
CostOfRevenue
4536000
us-gaap Cost Of Revenue
CostOfRevenue
3490000
CY2023Q3 us-gaap Gross Profit
GrossProfit
8820000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4846000
us-gaap Gross Profit
GrossProfit
23454000
us-gaap Gross Profit
GrossProfit
11803000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2696000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2293000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9392000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6906000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15652000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12679000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47504000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35945000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18348000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14972000
us-gaap Operating Expenses
OperatingExpenses
56896000
us-gaap Operating Expenses
OperatingExpenses
42851000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9528000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10126000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33442000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31048000
CY2023Q3 us-gaap Interest Expense
InterestExpense
499000
CY2022Q3 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
1220000
us-gaap Interest Expense
InterestExpense
0
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1056000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
328000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2734000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
237000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8971000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9798000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31928000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30811000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
108000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9011000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
us-gaap Net Income Loss
NetIncomeLoss
-32036000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9032000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9838000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32037000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30913000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20801350
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20801350
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20576838
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20576838
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20730024
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20730024
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20512254
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20512254
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
89964000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
363000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1532000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9011000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
82827000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
929000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
118244000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
519000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
452000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4713000
us-gaap Net Income Loss
NetIncomeLoss
-32036000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
82827000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
81000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2822000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
118244000
us-gaap Profit Loss
ProfitLoss
-32036000
us-gaap Profit Loss
ProfitLoss
-30892000
us-gaap Share Based Compensation
ShareBasedCompensation
4713000
us-gaap Share Based Compensation
ShareBasedCompensation
2822000
us-gaap Depreciation
Depreciation
393000
us-gaap Depreciation
Depreciation
284000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
114000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
868000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2737000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3930000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2184000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-902000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
479000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-586000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
766000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
112000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
584000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31182000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31836000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
422000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
606000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-422000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
519000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
81000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
452000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
295000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
7500000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
67000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8404000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
376000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-21000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23201000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32087000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106194000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82993000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109985000
us-gaap Interest Paid Net
InterestPaidNet
979000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4875000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2390000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1173000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4839000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3534000
CY2023Q3 us-gaap Inventory Net
InventoryNet
10887000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4382000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3978000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2659000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2280000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1723000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023Q3 us-gaap Depreciation
Depreciation
137000
CY2022Q3 us-gaap Depreciation
Depreciation
127000
us-gaap Depreciation
Depreciation
393000
us-gaap Depreciation
Depreciation
284000
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2366000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2303000
CY2023Q3 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
1212000
CY2022Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
960000
CY2023Q3 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
892000
CY2022Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1733000
CY2023Q3 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
382000
CY2022Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
256000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
280000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
170000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
103000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
120000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
869000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
775000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6274000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
10000000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
706000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14294000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1058000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
334000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
170000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
916000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1086000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
339000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
59000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
223000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
255000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
262000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
270000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
161000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1230000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
144000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1086000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2822000
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2023Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P4Y10M24D
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050
us-gaap Operating Lease Payments
OperatingLeasePayments
300000
us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3756835
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.28
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36616000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1086876
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
264160
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.42
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
115455
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.50
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4464096
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.66
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37331000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2311211
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.05
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25374000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1532000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
929000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4713000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2822000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1532000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
929000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4713000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
108000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9011000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
us-gaap Net Income Loss
NetIncomeLoss
-32036000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20801350
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20576838
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20730024
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20512254
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5180227
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4439630
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
0
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10511000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6186000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27990000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15293000

Files In Submission

Name View Source Status
0001558370-23-017121-index-headers.html Edgar Link pending
0001558370-23-017121-index.html Edgar Link pending
0001558370-23-017121.txt Edgar Link pending
0001558370-23-017121-xbrl.zip Edgar Link pending
cvrx-20230930.xsd Edgar Link pending
cvrx-20230930x10q.htm Edgar Link pending
cvrx-20230930xex31d1.htm Edgar Link pending
cvrx-20230930xex31d2.htm Edgar Link pending
cvrx-20230930xex32d1.htm Edgar Link pending
cvrx-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
cvrx-20230930_cal.xml Edgar Link unprocessable
cvrx-20230930_def.xml Edgar Link unprocessable
cvrx-20230930_lab.xml Edgar Link unprocessable
cvrx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cvrx-20230930x10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending